Yes, Cosentyx (secukinumab) is indeed an FDA-approved treatment for adults with moderate to severe hidradenitis suppurativa (HS). It is administered as a subcutaneous injection every four weeks, and in some cases, it may be given every two weeks if the initial response is not sufficient. Cosentyx works as an Show Full Answer

Yes, Cosentyx (secukinumab) is indeed an FDA-approved treatment for adults with moderate to severe hidradenitis suppurativa (HS). It is administered as a subcutaneous injection every four weeks, and in some cases, it may be given every two weeks if the initial response is not sufficient. Cosentyx works as an immunomodulator, specifically targeting and inhibiting interleukin 17A, which is thought to play a role in the inflammation associated with HS. If your doctor is considering switching you from another treatment like Humira to Cosentyx, it could be due to its specific action on the immune system pathways involved in HS. Always discuss the potential benefits and risks with your healthcare provider.

 This AI-generated response comes from myHSteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Cosentyx (Secukinumab) for Hidradenitis suppurativa | myHSteam

Treatments for Hidradenitis Suppurativa (HS) | myHSteam